iPhone 14 Pro Max
ƒ/1.78
6.86 mm
1/271
80
This morning, Kentucky announced $42mm in funding for Ibogaine research, as well as public-private partnerships to help push Ibogaine through the FDA approval process. The funds are coming from a large pool of Opioid Settlement Funds and will be allocated over the next 7 years. See the full press conference video here.
Graph above: pre-print Ibogaine work with Nolan Williams at Stanford Psychedelic Science Symposium with strong results in an open label trial, with 6-month followup.
One treatment session with ibogaine led to 80-90% remission rates for PTSD, depression, anxiety, alcoholism AND opiate use disorder in 30 Navy Seals diagnosed with Traumatic Brain Injury.
Leave a Reply